Srdjan R. Stankovic is President of ACADIA PHARMACEUTICALS INC. Currently has a direct ownership of 61,234 shares of ACAD, which is worth approximately $1.05 Million. The most recent transaction as insider was on Jan 06, 2021, when has been sold 5,444 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 61.2K
0% 3M change
0% 12M change
Total Value Held $1.05 Million

Srdjan R. Stankovic Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 06 2021
BUY
Exercise of conversion of derivative security
-
5,444 Added 19.86%
21,972 Common Stock
Nov 20 2020
SELL
Open market or private sale
$145,948 $53.5 p/Share
2,728 Reduced 14.17%
16,528 Common Stock
Nov 19 2020
BUY
Exercise of conversion of derivative security
-
6,250 Added 24.5%
19,256 Common Stock
Oct 16 2020
SELL
Open market or private sale
$55,200 $42.56 p/Share
1,297 Reduced 9.07%
13,006 Common Stock
Oct 15 2020
BUY
Exercise of conversion of derivative security
-
2,969 Added 17.19%
14,303 Common Stock
SRS

Srdjan R. Stankovic

President
San Diego, CA

Track Institutional and Insider Activities on ACAD

Follow ACADIA PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ACAD shares.

Notify only if

Insider Trading

Get notified when an Acadia Pharmaceuticals Inc insider buys or sells ACAD shares.

Notify only if

News

Receive news related to ACADIA PHARMACEUTICALS INC

Track Activities on ACAD